NExTRAC Meeting

Virtual Meeting

Federal Register Notice

Webcast

Agenda

  • NIH NExTRAC June 2021 Meeting Agenda (Needs Link)

Draft Report of the Gene Drives in Biomedical Research Working Group

  • Draft Report of the Gene Drives in Biomedical Research Working Group (Needs Link)

This is the draft report of the Gene Drives in Biomedical Research Working Group, which was prepared in response to the charge given by the NIH Director at the December 2019 NExTRAC meeting to:

  • “Consider whether existing biosafety guidance is adequate for contained laboratory research utilizing gene drive technology
  • Outline conditions (if any) under which NIH could consider supporting field release of gene drive modified organisms

and to provide advice on the following issues:

  • Given the diverse applications and species that may be used in gene drive research with different risks, is the current landscape of biosafety guidance adequate for contained research?
  • What knowledge and conditions should be in place to help ensure that field release research of gene drive modified organisms could be conducted safely and ethically?”

Additional Meeting Materials

This material contains content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: SciencePolicy@od.nih.gov.

  • NExTRAC Roster (Needs Link)
  • Gene Drives in Biomedical Research Working Group Roster (Needs Link)
  • NExTRAC Gene Drives in Biomedical Research Working Group, Cinnamon Bloss, Ph.D. and Zach Adelman, Ph.D. June 25, 2021 (Needs Link)
  • Charge to the NExTRAC, Lawrence A. Tabak, D.D.S., Ph.D. June, 25 2021 (Needs Link)

Public Comments (Needs Link)

Novel and Exceptional Technology and Research Advisory Committee (NExTRAC)

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will meet to discuss 1) pathways for responsible innovation in emerging biotechnologies; 2) characteristics of emerging biotechnologies, including presentations on horizon scanning, gene editing in the clinic, gene drives, neurotechnology, artificial intelligence, and synthetic biology; and 3) proactively addressing scientific and societal implications of emerging biotechnologies. In addition, charge(s) to the committee will be presented. Registration is not required to attend this meeting.

Agenda

Videocast

Visitor Information

Novel and Exceptional Technology and Research Advisory Committee

The John Edward Porter Neuroscience Research Center

Webcasts

Agenda

Minutes

Slides

Public Comments